Diminished thymosin alpha-1 levels in persons exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Stehr-Green. P A PA; Naylor. P H PH; Hoffman. R E RE
Key Findings
- Mean thymosin‑alpha‑1 levels were significantly lower in TCDD‑exposed individuals (977 pg/ml) compared to unexposed controls (1,149 pg/ml).
- Longer residence in the contaminated area correlated with progressively lower thymosin‑alpha‑1 levels.
- No direct association was found between reduced thymosin‑alpha‑1 and measurable immune function deficits in the exposed group.
Practical Outcomes
- The data suggest that chronic exposure to certain environmental toxins may suppress natural thymosin‑alpha‑1 production, which could be a hidden factor in immune health. While the study doesn’t prove a health problem, biohackers might consider monitoring toxin exposure and, if needed, exploring thymosin‑alpha‑1 supplementation as a precautionary measure.
Summary
People who lived for a long time in an area contaminated with the chemical TCDD had lower blood levels of the immune‑boosting peptide thymosin‑alpha‑1. The drop got bigger the longer they lived there, but the study didn’t find a clear link to actual immune problems.
Abstract
There is evidence from animal studies that 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) impairs immune responses, with the thymus being a principal target organ. The purpose of this study was to evaluate thymic function, through measurement of thymic hormone levels, in persons exposed to TCDD. We examined thymosin alpha-1 (Thya-1) levels in sera from a group of 94 persons who were presumed to be exposed to TCDD from living, working, or recreating in a contaminated residential area. We compared these results, along with results from in vitro and in vivo tests of immune function, with those from a group of 105 unexposed persons who were similar with regard to age, sex, and race. The exposed group had a significantly lower mean Thya-1 serum level (977.3 +/- 304.1 pg/ml vs. 1148.7 +/- 482.1 pg/ml, p less than .01 by t-test). We also found a statistically significant trend of decreasing Thya-1 levels with increasing number of years of residence in the TCDD-contaminated area. However, Thya-1 levels were not associated with other measures of immune function in the TCDD-exposed group. Thus, while the principal findings suggest that long-term TCDD exposure may be associated with diminished secretion of Thya-1, the lack of an association with an increased prevalence of clinically diagnosed immune suppression in these TCDD-exposed persons makes the biologic significance of the findings unclear. Further studies are needed to more fully evaluate possible long-term TCDD-induced effects on the thymus and human immune function.
Study Information
pubmed
1989
10.1080/15287398909531349
18
22